1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical characteristics of the study populationa
Characteristics Total (n = 102) Progression (n = 87) Nonprogression (n = 15) P Value Mean age (yr) 56.9 59.2 ± 13.5 51.3 ± 14.0 .04b Mean radiation dose (Gy) 51.9 52.5 ± 18.4 48.6 ± 0.6 .43b Sex .40c Male 59 52 7 Female 43 35 8 Methylated MGMT promoter .09c Positive 59 47 12 Negative 42 39 3 IDH1/2 mutation .28c Positive 7 5 2 Negative 94 81 13